Every cell in your body carries a molecular timestamp. Written not in base pairs but in methyl groups — tiny chemical tags that accumulate on your DNA in patterns so predictable they can estimate your age within months. These are epigenetic clocks, and they represent the most significant advance in aging measurement since the discovery of telomere attrition.
From Horvath to DunedinPACE: Three Generations of Clocks
The first-generation Horvath clock, published in 2013, was trained on 8,000 samples across 51 tissue types. It measured biological age — a snapshot of cumulative aging. Second-generation clocks like GrimAge incorporated mortality-related biomarkers, adding predictive power. But the real breakthrough came with DunedinPACE, a third-generation clock that measures something different entirely: the speed of aging.
DunedinPACE was developed from the Dunedin longitudinal study, which tracked 1,037 individuals from birth to age 45. By measuring methylation changes over time within the same individuals, researchers could calculate a pace metric: how many biological years elapse per calendar year. A DunedinPACE of 1.0 means you're aging at the expected rate. Below 1.0, you're aging slower. Above, faster.
“Biological age tells you where you are. DunedinPACE tells you how fast you're getting there. Both matter, but the pace is what you can change.”
What Accelerates Epigenetic Aging
- Chronic inflammation — the single strongest accelerator, driven by visceral adiposity, poor sleep, and chronic stress
- Metabolic dysfunction — insulin resistance shifts methylation patterns toward accelerated aging within months
- Environmental toxins — heavy metals, air pollution, and endocrine disruptors leave measurable epigenetic signatures
- Sleep deprivation — consistently sleeping less than 6 hours accelerates epigenetic age by 2-3 years over a decade
- Psychological stress — ACE (adverse childhood experience) scores correlate with accelerated GrimAge
The Intervention Landscape
If epigenetic aging can be measured, can it be reversed? The evidence says yes — cautiously. The Fitzgerald trial (2021) demonstrated a mean 3.23-year biological age reduction in 8 weeks through a combined diet, exercise, sleep, and supplementation protocol. Longer interventions show even more promise. Caloric restriction, rapamycin analogs, senolytics, and NAD+ precursors have all demonstrated epigenetic age reversal in human or near-human models.
The future of longevity medicine is written in methyl groups. The institutions that measure them rigorously, interpret them precisely, and intervene upon them systematically will define the next era of preventive care. We intend to be one of them.
